|
Ontario, Canada
|
|
98-1220792
|
(State or other jurisdiction of incorporation or organization)
|
|
(IRS Employer Identification No.)
|
|
|
|
895 Don Mills Road, Bldg. 2, Suite 900
|
|
|
Toronto, Ontario, Canada, M3C 1W3
|
|
|
(Address of principal executive offices)
|
|
|
|
|
|
|||
|
|
|
|
|
Item 1.
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
Item 2.
|
|
|
||
|
|
|
|
|
Item 3.
|
|
|
||
|
|
|
|
|
Item 4.
|
|
|
||
|
|
|
|
|
|
|
|||
|
|
|
|
|
Item 1.
|
|
|
||
|
|
|
|
|
Item 1A.
|
|
|
||
|
|
|
|
|
Item 2.
|
|
|
||
|
|
|
|
|
Item 3.
|
|
|
||
|
|
|
|
|
Item 4.
|
|
|
||
|
|
|
|
|
Item 5.
|
|
|
||
|
|
|
|
|
Item 6.
|
|
|
||
|
|
|
|
|
|
|
|
|
Three Months
Ended June 30, |
|
Six Months
Ended June 30, |
||||||||||||
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
|
|
|
|
|
|
|
|
||||||||
|
(Unaudited)
|
|
(Unaudited)
|
||||||||||||
Revenue
|
$
|
963
|
|
|
$
|
2,698
|
|
|
$
|
3,093
|
|
|
$
|
5,071
|
|
Cost of revenue
|
718
|
|
|
2,225
|
|
|
2,153
|
|
|
4,155
|
|
||||
Gross profit
|
245
|
|
|
473
|
|
|
940
|
|
|
916
|
|
||||
Operating expenses:
|
|
|
|
|
|
|
|
||||||||
Sales and marketing
|
491
|
|
|
740
|
|
|
944
|
|
|
1,521
|
|
||||
Research and development
|
516
|
|
|
899
|
|
|
1,213
|
|
|
2,010
|
|
||||
General and administrative
|
761
|
|
|
1,691
|
|
|
2,013
|
|
|
4,691
|
|
||||
|
1,768
|
|
|
3,330
|
|
|
4,170
|
|
|
8,222
|
|
||||
Loss from operations
|
(1,523
|
)
|
|
(2,857
|
)
|
|
(3,230
|
)
|
|
(7,306
|
)
|
||||
Other income (expense):
|
|
|
|
|
|
|
|
||||||||
Interest expense, related party
|
(144
|
)
|
|
(1,212
|
)
|
|
(286
|
)
|
|
(1,770
|
)
|
||||
Interest expense
|
(12
|
)
|
|
—
|
|
|
(15
|
)
|
|
—
|
|
||||
Other income (expense), net
|
14
|
|
|
41
|
|
|
22
|
|
|
(85
|
)
|
||||
Net loss from continuing operations
|
(1,665
|
)
|
|
(4,028
|
)
|
|
(3,509
|
)
|
|
(9,161
|
)
|
||||
Net loss from discontinued operations
|
—
|
|
|
(1,974
|
)
|
|
—
|
|
|
(3,664
|
)
|
||||
Net loss
|
$
|
(1,665
|
)
|
|
$
|
(6,002
|
)
|
|
$
|
(3,509
|
)
|
|
$
|
(12,825
|
)
|
Net loss per share:
|
|
|
|
|
|
|
|
||||||||
Continuing operations
|
$
|
(0.72
|
)
|
|
$
|
(2.36
|
)
|
|
$
|
(1.55
|
)
|
|
$
|
(6.86
|
)
|
Discontinued operations
|
$
|
—
|
|
|
$
|
(1.16
|
)
|
|
—
|
|
|
(2.75
|
)
|
||
Net loss per share basic and diluted
|
$
|
(0.72
|
)
|
|
$
|
(3.52
|
)
|
|
$
|
(1.55
|
)
|
|
$
|
(9.61
|
)
|
Shares used in computing net loss per share:
|
|
|
|
|
|
|
|
||||||||
Basic and diluted
|
2,300,469
|
|
|
1,706,289
|
|
|
2,268,706
|
|
|
1,335,104
|
|
|
Three Months
Ended June 30, |
|
Six Months
Ended June 30, |
||||||||||||
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
|
|
|
|
|
|
|
|
||||||||
|
(Unaudited)
|
|
(Unaudited)
|
||||||||||||
Net loss
|
$
|
(1,665
|
)
|
|
$
|
(6,002
|
)
|
|
$
|
(3,509
|
)
|
|
$
|
(12,825
|
)
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
||||||||
Foreign currency translation adjustment
|
2
|
|
|
(407
|
)
|
|
42
|
|
|
234
|
|
||||
Total other comprehensive income (loss)
|
2
|
|
|
(407
|
)
|
|
42
|
|
|
234
|
|
||||
Comprehensive loss
|
$
|
(1,663
|
)
|
|
$
|
(6,409
|
)
|
|
$
|
(3,467
|
)
|
|
$
|
(12,591
|
)
|
|
June 30,
2019 |
|
December 31,
2018 |
||||
|
|
|
|
||||
Assets
|
(Unaudited)
|
||||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
151
|
|
|
$
|
341
|
|
Accounts receivable, net
|
500
|
|
|
1,142
|
|
||
Inventories
|
1,170
|
|
|
1,230
|
|
||
Other current assets
|
703
|
|
|
784
|
|
||
Total current assets
|
2,524
|
|
|
3,497
|
|
||
Investment in affiliate
|
2,100
|
|
|
2,100
|
|
||
Property and equipment, net
|
5
|
|
|
6
|
|
||
Intangible assets, net
|
2,873
|
|
|
3,348
|
|
||
Goodwill
|
1,385
|
|
|
1,385
|
|
||
Other assets
|
1,025
|
|
|
950
|
|
||
Total assets
|
$
|
9,912
|
|
|
$
|
11,286
|
|
Liabilities and Shareholders’ Deficit
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
5,305
|
|
|
$
|
4,600
|
|
Accrued liabilities
|
1,761
|
|
|
1,711
|
|
||
Accrued payroll and employee compensation
|
1,714
|
|
|
1,717
|
|
||
Deferred revenue
|
721
|
|
|
988
|
|
||
Debt, related party
|
500
|
|
|
500
|
|
||
Line of credit
|
389
|
|
|
100
|
|
||
Other current liabilities
|
103
|
|
|
23
|
|
||
Total current liabilities
|
10,493
|
|
|
9,639
|
|
||
Series A redeemable preferred shares
|
6,832
|
|
|
6,571
|
|
||
Deferred revenue, long-term
|
679
|
|
|
667
|
|
||
Long-term debt, related party
|
523
|
|
|
—
|
|
||
Other non-current liabilities
|
113
|
|
|
16
|
|
||
Total liabilities
|
18,640
|
|
|
16,893
|
|
||
Commitments and contingencies (Note 14)
|
|
|
|
|
|
||
Shareholders’ deficit:
|
|
|
|
||||
Common shares, no par value; 2,303,088 and 2,219,141 shares issued and outstanding as of June 30, 2019 and December 31, 2018, respectively
|
183,870
|
|
|
183,524
|
|
||
Accumulated other comprehensive loss
|
(1,774
|
)
|
|
(1,816
|
)
|
||
Accumulated deficit
|
(190,824
|
)
|
|
(187,315
|
)
|
||
Total shareholders’ deficit
|
(8,728
|
)
|
|
(5,607
|
)
|
||
Total liabilities and shareholders’ deficit
|
$
|
9,912
|
|
|
$
|
11,286
|
|
|
Six Months
Ended June 30, |
||||||
|
2019
|
|
2018
|
||||
|
|
|
|
||||
Operating activities:
|
(Unaudited)
|
||||||
Net loss
|
$
|
(3,509
|
)
|
|
$
|
(12,825
|
)
|
Adjustments to reconcile net loss to cash used in operating activities:
|
|
|
|
||||
Depreciation and amortization
|
520
|
|
|
2,410
|
|
||
Share-based compensation
|
240
|
|
|
1,265
|
|
||
Preferred shares interest expense, related party
|
261
|
|
|
—
|
|
||
Amortization of debt issuance costs
|
—
|
|
|
1,532
|
|
||
Fair value adjustment of warrants
|
—
|
|
|
(259
|
)
|
||
Payment in-kind interest expense, related party
|
—
|
|
|
129
|
|
||
Changes in operating assets and liabilities:
|
|
|
|
||||
Accounts receivable
|
641
|
|
|
2,549
|
|
||
Inventories
|
61
|
|
|
990
|
|
||
Accounts payable and accrued liabilities
|
672
|
|
|
2,064
|
|
||
Accrued payroll and employee compensation
|
182
|
|
|
(263
|
)
|
||
Deferred revenue
|
(256
|
)
|
|
(721
|
)
|
||
Other assets and liabilities, net
|
186
|
|
|
(343
|
)
|
||
Net cash used in operating activities
|
(1,002
|
)
|
|
(3,472
|
)
|
||
Investing activities:
|
|
|
|
||||
Purchase of property and equipment
|
—
|
|
|
(31
|
)
|
||
Net cash used in investing activities
|
—
|
|
|
(31
|
)
|
||
Financing activities:
|
|
|
|
||||
Proceeds from debt - related party
|
523
|
|
|
—
|
|
||
Proceeds from line of credit, net
|
289
|
|
|
—
|
|
||
Proceeds from issuance of common shares and warrants
|
—
|
|
|
2,310
|
|
||
Payment for issuance costs
|
—
|
|
|
(359
|
)
|
||
Payments on debt, related party
|
—
|
|
|
(192
|
)
|
||
Net cash provided by financing activities
|
812
|
|
|
1,759
|
|
||
Effect of exchange rate changes on cash
|
—
|
|
|
4
|
|
||
Net decrease in cash and cash equivalents
|
(190
|
)
|
|
(1,740
|
)
|
||
Cash and cash equivalents, beginning of period
|
341
|
|
|
4,598
|
|
||
Cash and cash equivalents, end of period
|
151
|
|
|
2,858
|
|
||
Less: Cash and cash equivalents, discontinued operations
|
—
|
|
|
2,574
|
|
||
Cash and cash equivalents of continuing operations, end of period
|
$
|
151
|
|
|
$
|
284
|
|
Supplemental disclosures of cash flow information:
|
|
|
|
||||
Cash paid for interest
|
$
|
19
|
|
|
$
|
633
|
|
Supplemental disclosures of non-cash financing activities:
|
|
|
|
||||
Issuance of common shares for settlement of related party liabilities
|
$
|
—
|
|
|
$
|
1,393
|
|
Issuance of common shares for settlement of liabilities
|
$
|
105
|
|
|
$
|
1,162
|
|
Costs accrued for issuance of common shares
|
$
|
—
|
|
|
$
|
191
|
|
|
Common Shares
|
|
Accumulated
Other Comprehensive Loss |
|
Accumulated
Deficit |
|
Total
Shareholders' Deficit |
|||||||||||
|
Shares
|
|
Amount
|
|
||||||||||||||
Balance at January 1, 2019
|
2,219,141
|
|
|
$
|
183,524
|
|
|
$
|
(1,816
|
)
|
|
$
|
(187,315
|
)
|
|
$
|
(5,607
|
)
|
Issuance of common shares pursuant to the vesting of
restricted stock units |
38,930
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Issuance of restricted stock awards
|
42,000
|
|
|
105
|
|
|
—
|
|
|
—
|
|
|
105
|
|
||||
Share-based compensation
|
—
|
|
|
124
|
|
|
—
|
|
|
—
|
|
|
124
|
|
||||
Other comprehensive income
|
—
|
|
|
—
|
|
|
40
|
|
|
—
|
|
|
40
|
|
||||
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,844
|
)
|
|
(1,844
|
)
|
||||
Balance at March 31, 2019
|
2,300,071
|
|
|
183,753
|
|
|
(1,776
|
)
|
|
(189,159
|
)
|
|
(7,182
|
)
|
||||
Issuance of common shares pursuant to the vesting of
restricted stock units |
3,017
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Share-based compensation
|
—
|
|
|
117
|
|
|
—
|
|
|
—
|
|
|
117
|
|
||||
Other comprehensive income
|
—
|
|
|
—
|
|
|
2
|
|
|
—
|
|
|
2
|
|
||||
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,665
|
)
|
|
(1,665
|
)
|
||||
Balance at June 30, 2019
|
2,303,088
|
|
|
$
|
183,870
|
|
|
$
|
(1,774
|
)
|
|
$
|
(190,824
|
)
|
|
$
|
(8,728
|
)
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Common Shares
|
|
Accumulated
Other Comprehensive Loss |
|
Accumulated
Deficit |
|
Total
Shareholders' Equity |
|||||||||||
|
Shares
|
|
Amount
|
|
||||||||||||||
Balance at January 1, 2018
|
889,461
|
|
|
$
|
173,871
|
|
|
$
|
(1,981
|
)
|
|
$
|
(161,427
|
)
|
|
$
|
10,463
|
|
Adoption of accounting standards
|
—
|
|
|
—
|
|
|
—
|
|
|
320
|
|
|
320
|
|
||||
Issuance of common shares for warrant exchange
|
178,875
|
|
|
1,364
|
|
|
—
|
|
|
—
|
|
|
1,364
|
|
||||
Issuance of common shares for settlement of related party
interest expense
|
43,120
|
|
|
483
|
|
|
—
|
|
|
—
|
|
|
483
|
|
||||
Issuance of common shares pursuant to the vesting of
restricted stock units
|
26,353
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Issuance of restricted stock awards
|
40,654
|
|
|
787
|
|
|
—
|
|
|
—
|
|
|
787
|
|
||||
Share-based compensation
|
—
|
|
|
821
|
|
|
—
|
|
|
—
|
|
|
821
|
|
||||
Other comprehensive income
|
—
|
|
|
—
|
|
|
641
|
|
|
—
|
|
|
641
|
|
||||
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
(6,823
|
)
|
|
(6,823
|
)
|
||||
Balance at March 31, 2018
|
1,178,463
|
|
|
177,326
|
|
|
(1,340
|
)
|
|
(167,930
|
)
|
|
8,056
|
|
||||
Issuance of common shares and warrants for cash, net
|
492,600
|
|
|
2,067
|
|
|
—
|
|
|
—
|
|
|
2,067
|
|
||||
Issuance of common shares for settlement of related party
interest expense |
176,250
|
|
|
910
|
|
|
—
|
|
|
—
|
|
|
910
|
|
||||
Issuance of common shares pursuant to the vesting of
restricted stock units |
22,246
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Issuance of restricted stock awards
|
36,665
|
|
|
119
|
|
|
—
|
|
|
—
|
|
|
119
|
|
||||
Share-based compensation
|
—
|
|
|
444
|
|
|
—
|
|
|
—
|
|
|
444
|
|
||||
Other comprehensive loss
|
—
|
|
|
—
|
|
|
(407
|
)
|
|
—
|
|
|
(407
|
)
|
||||
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
(6,002
|
)
|
|
(6,002
|
)
|
||||
Balance at June 30, 2018
|
1,906,224
|
|
|
$
|
180,866
|
|
|
$
|
(1,747
|
)
|
|
$
|
(173,932
|
)
|
|
$
|
5,187
|
|
1.
|
Organization and Business
|
2.
|
Significant Accounting Policies
|
3.
|
Discontinued Operations
|
|
|
Three Months
Ended
|
|
Six Months
Ended
|
||||
|
|
June 30, 2018
|
||||||
Revenue
|
|
$
|
15,764
|
|
|
$
|
32,839
|
|
Cost of revenue
|
|
10,516
|
|
|
22,023
|
|
||
Gross profit
|
|
5,248
|
|
|
10,816
|
|
||
Sales and marketing
|
|
3,275
|
|
|
6,884
|
|
||
Research and development
|
|
130
|
|
|
307
|
|
||
General and administrative
|
|
2,338
|
|
|
4,760
|
|
||
|
|
5,743
|
|
|
11,951
|
|
||
Loss from operations of discontinued operations
|
|
(495
|
)
|
|
(1,135
|
)
|
||
Other expense of discontinued operations:
|
|
|
|
|
||||
Interest expense, related party
|
|
(66
|
)
|
|
(163
|
)
|
||
Interest expense
|
|
(1,006
|
)
|
|
(1,459
|
)
|
||
Other income (expense), net
|
|
82
|
|
|
(78
|
)
|
||
Loss before income taxes of discontinued operations
|
|
(1,485
|
)
|
|
(2,835
|
)
|
||
Provision for income taxes of discontinued operations
|
|
489
|
|
|
829
|
|
||
Net loss of discontinued operations
|
|
$
|
(1,974
|
)
|
|
$
|
(3,664
|
)
|
|
|
Six Months Ended
June 30, 2018
|
||
Depreciation and amortization
|
|
$
|
1,386
|
|
Capital expenditures
|
|
$
|
31
|
|
4.
|
Certain Balance Sheet Items
|
|
June 30,
2019 |
|
December 31,
2018
|
||||
Raw materials
|
$
|
218
|
|
|
$
|
255
|
|
Work in process
|
286
|
|
|
282
|
|
||
Finished goods
|
666
|
|
|
693
|
|
||
|
$
|
1,170
|
|
|
$
|
1,230
|
|
|
June 30,
2019 |
|
December 31, 2018
|
||||
Deferred cost - service contracts
|
$
|
246
|
|
|
$
|
385
|
|
Prepaid insurance and services
|
194
|
|
|
344
|
|
||
Other
|
263
|
|
|
55
|
|
||
|
$
|
703
|
|
|
$
|
784
|
|
|
June 30,
2019 |
|
December 31, 2018
|
||||
Prepaid insurance and services
|
$
|
586
|
|
|
$
|
653
|
|
Deferred cost – service contracts
|
212
|
|
|
270
|
|
||
Right-of-use asset
|
198
|
|
|
—
|
|
||
Other
|
29
|
|
|
27
|
|
||
|
$
|
1,025
|
|
|
$
|
950
|
|
5.
|
Intangible Assets
|
|
June 30,
2019 |
|
December 31,
2018
|
||||
Developed technology
|
$
|
13,323
|
|
|
$
|
13,383
|
|
Channel partner relationships
|
730
|
|
|
730
|
|
||
Capitalized development costs
(1)
|
3,024
|
|
|
2,918
|
|
||
Customer relationships
|
380
|
|
|
380
|
|
||
|
17,457
|
|
|
17,411
|
|
||
Accumulated amortization:
|
|
|
|
||||
Developed technology
|
(12,422
|
)
|
|
(12,222
|
)
|
||
Channel partner relationships
|
(294
|
)
|
|
(233
|
)
|
||
Capitalized development costs
(1)
|
(1,897
|
)
|
|
(1,655
|
)
|
||
Customer relationships
|
(321
|
)
|
|
(303
|
)
|
||
|
(14,934
|
)
|
|
(14,413
|
)
|
||
Total finite-lived assets, net
|
2,523
|
|
|
2,998
|
|
||
Indefinite-lived intangible assets - trade names
|
350
|
|
|
350
|
|
||
Total intangible assets, net
|
$
|
2,873
|
|
|
$
|
3,348
|
|
(1)
|
Includes the impact of foreign currency exchange rate fluctuations.
|
6.
|
Investment in Affiliate
|
7.
|
Debt
|
8.
|
Preferred Shares
|
9.
|
Fair Value Measurements
|
10.
|
Share Capital
|
Date issued
|
|
Contractual life (years)
|
|
Exercise price
|
|
Number outstanding
|
|
Expiration
|
|
May 2015
|
|
5
|
|
$800.00
|
|
4,200
|
|
|
May 31, 2020
|
October 2015
|
|
5
|
|
$466.00
|
|
2,010
|
|
|
October 14, 2020
|
December 2015
|
|
5
|
|
$500.00
|
|
5,138
|
|
|
December 15, 2020
|
December 2015
|
|
5
|
|
$216.00
|
|
7,500
|
|
(1)
|
December 4, 2020
|
March 2016
|
|
5
|
|
$500.00
|
|
150
|
|
|
March 4, 2021
|
November 2016
|
|
3
|
|
$400.00
|
|
125
|
|
|
November 8, 2019
|
August 2017
|
|
5
|
|
$42.00
|
|
37,500
|
|
|
August 11, 2022
|
August 2017
|
|
5
|
|
$42.00
|
|
11,876
|
|
|
August 16, 2022
|
August 2017
|
|
5
|
|
$42.00
|
|
25,625
|
|
|
August 22, 2022
|
April 2018
|
|
5
|
|
$5.60
|
|
111,563
|
|
|
April 17, 2023
|
|
|
|
|
|
|
205,687
|
|
(2)
|
|
(1)
|
If the Company or any subsidiary thereof, at any time while this warrant is outstanding, enters into a Variable Rate Transaction (“VRT”) (as defined in the purchase agreement) and the issue price, conversion price or exercise price per share applicable thereto is less than the warrant exercise price then in effect, the exercise price shall be reduced to equal the VRT price.
|
(2)
|
Includes warrants to purchase up to
40,000
common shares, in the aggregate, outstanding to related parties at
June 30, 2019
.
|
11.
|
Equity Incentive Plans
|
|
Three Months
Ended June 30, |
|
Six Months
Ended June 30, |
||||||||||||
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Cost of sales
|
$
|
(487
|
)
|
|
$
|
10,461
|
|
|
$
|
205
|
|
|
$
|
42,544
|
|
Sales and marketing
|
69,004
|
|
|
93,572
|
|
|
79,317
|
|
|
277,347
|
|
||||
Research and development
|
18,150
|
|
|
57,692
|
|
|
36,621
|
|
|
153,992
|
|
||||
General and administrative
|
29,491
|
|
|
282,401
|
|
|
124,056
|
|
|
791,026
|
|
||||
Total share-based compensation expense
|
$
|
116,158
|
|
|
$
|
444,126
|
|
|
$
|
240,199
|
|
|
$
|
1,264,909
|
|
12.
|
Net Loss per Share
|
|
Six Months
Ended June 30, |
||||
|
2019
|
|
2018
|
||
Common share purchase warrants
|
205,687
|
|
|
248,087
|
|
Restricted stock not yet vested or released
|
110,993
|
|
|
76,838
|
|
Options outstanding
|
6,838
|
|
|
20,991
|
|
Convertible notes
|
—
|
|
|
40,833
|
|
13.
|
Related Party Transactions
|
14.
|
Commitments and Contingencies
|
|
Product
Warranty |
|
Deferred
Revenue |
||||
Liability at January 1, 2019
|
$
|
22
|
|
|
$
|
1,471
|
|
Settlements made during the period
|
—
|
|
|
(564
|
)
|
||
Change in liability for warranties issued during the period
|
—
|
|
|
312
|
|
||
Change in liability for pre-existing warranties
|
(22
|
)
|
|
—
|
|
||
Liability at June 30, 2019
|
$
|
—
|
|
|
$
|
1,219
|
|
Current liability
|
$
|
—
|
|
|
$
|
541
|
|
Non-current liability
|
—
|
|
|
678
|
|
||
Liability at June 30, 2019
|
$
|
—
|
|
|
$
|
1,219
|
|
15.
|
Subsequent Events
|
•
|
On July 29, 2019, the Company completed a private placement and issued
240,000
common shares of the Company at a purchase price of
$2.00
per share for gross proceeds of
$480,000
. The Company intends to use the proceeds from the offering for general corporate and working capital purposes.
|
•
|
On July 12, 2019, following the filing of the Articles of Amendment to create the Series B Preferred Shares, the Company entered into a share exchange agreement (the “Share Exchange Agreement”) with FBC Holdings to exchange the
6,500,000
Series A Preferred Shares held by FBC Holdings for
6,500,000
Series B Preferred Shares.
|
•
|
On July 12, 2019, in connection with the Share Exchange Agreement, the Company entered into an amendment to the Exchange and Buy-Out Agreement by and among the Company, FBC Holdings, SVTP and MF Ventures LLC (“MFV”) such that the rights and obligations under the Exchange and Buy-Out Agreement would apply to the Series B Preferred Shares in respect of which the Series A Preferred Shares were exchanged under the Share Exchange Agreement.
|
•
|
On July 8, 2019, the directors of the Company passed a resolution authorizing the filing of articles of amendment to create a second series of Preferred Shares, being, an unlimited number of series B preferred shares (the “Series B Preferred Shares”) and to provide for the rights, privileges, restrictions and conditions attaching thereto. The rights, privileges, restrictions and conditions attaching to the Series B Preferred Shares are substantially the same as the series A preferred shares (the “Series A Preferred Shares”) of the Company, save and except that the requirement for the Company to redeem all of the issued and outstanding Series A Preferred Shares on or before November 13, 2020 has been amended to provide that the Company shall only be required to redeem
1,000,000
Series B Preferred Shares on or before November 13, 2020 and any other outstanding Series B Preferred Shares may be redeemed at any time and from time to time after December 19, 2019 at the option of the Company. On July 12, 2019, the Company filed Articles of Amendment to create the Series B Preferred Shares.
|
|
Three Months
Ended June 30, |
|
Six Months
Ended June 30, |
||||||||
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||
Revenue
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
Cost of revenue
|
74.6
|
|
|
82.5
|
|
|
69.6
|
|
|
81.9
|
|
Gross profit
|
25.4
|
|
|
17.5
|
|
|
30.4
|
|
|
18.1
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|||
Sales and marketing
|
51.0
|
|
|
27.4
|
|
|
30.5
|
|
|
30.0
|
|
Research and development
|
53.6
|
|
|
33.3
|
|
|
39.2
|
|
|
39.6
|
|
General and administrative
|
79.0
|
|
|
62.7
|
|
|
65.1
|
|
|
92.5
|
|
|
183.6
|
|
|
123.4
|
|
|
134.8
|
|
|
162.1
|
|
Loss from operations
|
(158.2
|
)
|
|
(105.9
|
)
|
|
(104.4
|
)
|
|
(144.0
|
)
|
Interest expense
|
(16.2
|
)
|
|
(44.9
|
)
|
|
(9.7
|
)
|
|
(34.9
|
)
|
Other income (expense), net
|
1.5
|
|
|
1.5
|
|
|
0.7
|
|
|
(1.7
|
)
|
Net loss from continuing operations
|
(172.9
|
)
|
|
(149.3
|
)
|
|
(113.4
|
)
|
|
(180.6
|
)
|
Net loss from discontinued operations
|
—
|
|
|
(73.2
|
)
|
|
—
|
|
|
(72.3
|
)
|
Net loss
|
(172.9
|
)%
|
|
(222.5
|
)%
|
|
(113.4
|
)%
|
|
(252.9
|
)%
|
|
|
Three Months
Ended June 30, |
|
|
|||||
|
|
2019
|
|
2018
|
|
Change
|
|||
Gross profit
|
|
245
|
|
|
473
|
|
|
(48.2
|
)%
|
Gross margin
|
|
25.4
|
%
|
|
17.5
|
%
|
|
7.9
|
pt
|
|
|
Six Months
Ended June 30, |
|
|
|||||
|
|
2019
|
|
2018
|
|
Change
|
|||
Gross profit
|
|
940
|
|
|
916
|
|
|
2.6
|
%
|
Gross margin
|
|
30.4
|
%
|
|
18.1
|
%
|
|
12.3
|
pt
|
|
|
Maturity Date
|
|
Interest Rate
|
|
Amount Outstanding
|
||
Series A redeemable preferred shares
|
|
11/13/2020
|
|
8.0%
|
|
$
|
6,832
|
|
Secured debt - related party
|
|
6/13/2019
|
|
8.0%
|
|
$
|
500
|
|
Unsecured debt - related party
|
|
1/10/2021
|
|
2.0%
|
|
$
|
523
|
|
Line of credit
|
|
12/19/2019
|
|
6.0%
|
|
$
|
389
|
|
|
|
Six Months
Ended June 30, |
||||||
|
|
2019
|
|
2018
|
||||
Net cash used in operating activities
|
|
$
|
(1,002
|
)
|
|
$
|
(3,472
|
)
|
Net cash used in investing activities
|
|
$
|
—
|
|
|
$
|
(31
|
)
|
Net cash provided by financing activities
|
|
$
|
812
|
|
|
$
|
1,759
|
|
Item 1.
|
Legal Proceedings.
|
Exhibit
|
|
Filed
|
Incorporated by Reference
|
||
Number
|
Description
|
Herewith
|
Form
|
File No.
|
Date Filed
|
|
|
|
|
|
|
3.1
|
|
6-K
|
001-36532
|
3/25/2015
|
|
|
|
|
|
|
|
3.2
|
|
6-K
|
001-36532
|
7/17/2017
|
|
|
|
|
|
|
|
3.3
|
|
8-K
|
001-36532
|
10/2/2018
|
|
|
|
|
|
|
|
3.4
|
|
8-K
|
001-36532
|
10/5/2018
|
|
|
|
|
|
|
|
3.5
|
|
8-K
|
001-36532
|
11/5/2018
|
|
|
|
|
|
|
|
3.6
|
|
8-K
|
001-36532
|
11/14/2018
|
|
|
|
|
|
|
|
3.7
|
|
8-K
|
001-36532
|
7/12/2019
|
|
|
|
|
|
|
|
3.8
|
|
6-K
|
001-36532
|
7/17/2017
|
|
|
|
|
|
|
|
3.9
|
|
6-K
|
001-36532
|
5/12/2017
|
|
|
|
|
|
|
|
10.1
|
|
10-Q
|
001-36532
|
5/15/2019
|
|
|
|
|
|
|
|
10.2
|
|
8-K
|
001-36532
|
7/12/2019
|
|
|
|
|
|
|
|
10.3
|
|
8-K
|
001-36532
|
7/12/2019
|
|
|
|
|
|
|
|
10.4
|
X
|
|
|
|
|
|
|
|
|
|
|
31.1
|
X
|
|
|
|
|
|
|
|
|
|
|
31.2
|
X
|
|
|
|
|
|
|
|
|
|
|
32
|
X
|
|
|
|
|
|
|
|
|
|
|
101.INS
|
XBRL Instance Document
|
X
|
|
|
|
|
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema
|
X
|
|
|
|
|
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase
|
X
|
|
|
|
|
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase
|
X
|
|
|
|
|
|
|
|
|
|
Exhibit
|
|
Filed
|
Incorporated by Reference
|
||
Number
|
Description
|
Herewith
|
Form
|
File No.
|
Date Filed
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase
|
X
|
|
|
|
|
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Presentation Linkbase
|
X
|
|
|
|
|
|
|
Sphere 3D Corp.
|
|
|
|
|
|
|
Date:
|
August 13, 2019
|
|
By:
|
/s/ Peter Tassiopoulos
|
|
|
|
|
Peter Tassiopoulos
Chief Executive Officer
(Principal Executive Officer)
|
PRIOR
OBLIGATION
INFORMATION
|
LOAN NUMBER
120011219
|
ACCT. NUMBER NOTE DATE
12/19/18
|
CREDIT LIMIT
$400,000.00
|
MATURITY DATE
12/19/19
|
AMENDED
OBLIGATION
INFORMATION
|
LOAN NUMBER
120011219
MATURITY DATE
12/19/19
|
ACCT. NUMBER
MODIFICATION DATE
July 2, 2019
INDEX (w/margin)
INTEREST RATE
Not Applicable 6.500%
Creditor Use Only
|
CREDIT LIMIT
$500,000.00
INITIALS
MES
|
A.
|
Pronouns.
The pronouns “I,” "me," and " my" refer to each Borrower signing this Modification and each other person or legal entity (including guarantors, endorsers, and sureties) who agrees to pay this Loan. "You" and "your" refer to the Lender, with its participants or syndicators, successors and assigns, or any person or entity that acquires an interest in the Modification or the Prior Obligation.
|
B.
|
Amended Obligation
. Amended Obligation is the resulting agreement that is created when the Modification amends the Prior Obligation. It is described above in the AMENDED OBLIGATION INFORMATION section.
|
C.
|
Credit Limit.
Credit Limit means the maximum amount of principal you will permit me to owe you under this Line of Credit, at any one time. My Credit Limit is stated at the top of this Modification.
|
D.
|
Loan.
Loan refers to this transaction generally. It includes the obligations and duties arising from the terms of all documents prepared or submitted in association with the Prior Obligation and this modification, such as applications, security agreements, disclosures, notes, agreements, and this Modification.
|
E.
|
Modification. Modification refers to this Debt Modification Agreement.
|
F.
|
Prior Obligation.
Prior Obligation refers to my original agreement described above in the PRIOR OBLIGATION INFORMATION section, and any subsequent extensions, renewals, modifications or substitutions of it.
|
2.
|
BACKGROUND.
You and I have previously entered into a Prior Obligation. As of the date of this Modification, the outstanding, unpaid balance of the Prior Obligation is $389,047.44. Conditions have changed since the execution of the Prior Obligation instruments. In response, and for value received, you and I agree to modify the terms of the Prior Obligation, as provided for in this Modification.
|
3.
|
CONTINUATION OF TERMS.
I agree and understand that all other terms and provisions in the Prior Obligation survive and continue in full force and effect, except to the extent that they are specifically and expressly amended by this Modification. The express amendment of a term does not amend related or other terms - even if the related or other terms are contained in the same section or paragraph of the Prior Obligation. For illustration purposes only, a modification of the interest rate to be paid during the term of the loan would not modify the default rate of interest even though both of those terms are described in the Prior Obligation in a common section titled "Interest". The term "Prior Obligation" includes the original instrument and any modifications prior to this Modification.
|
4.
|
TERMS.
The Prior Obligation is modified as follows:
|
A.
|
Promise to Pay.
My promise to pay is modified to read:
|
B.
|
Interest.
Our agreement for the payment of interest is modified to read:
|
C.
|
Payments.
The payment provision is modified to read:
|
D.
|
Fees and Charges
. As additional consideration for your consent to enter into this Modification, I agree to pay, or have paid these additional fees and charges:
|
5.
|
WAIVER.
I waive all claims, defenses, setoffs, or counterclaims relating to the Prior Obligation, or any document securing the Prior Obligation, that I may have. Any party to the Prior Obligation that does not sign this Modification, shall remain liable under the terms of the Prior Obligation unless released in writing by you.
|
6.
|
SIGNATURES. By signing, I agree to the terms contained in this Modification. I also acknowledge receipt of a copy of this Modification.
|
7.
|
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Sphere 3D Corp.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report;
|
4.
|
The company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:
|
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
(c)
|
Evaluated the effectiveness of the issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
(d)
|
Disclosed in this report any change in the issuer’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the issuer’s internal control over financial reporting; and
|
5.
|
The company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer’s auditors and the audit committee of the issuer’s board of directors (or persons performing the equivalent functions):
|
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer’s ability to record, process, summarize and report financial information; and
|
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer’s internal control over financial reporting.
|
/s/ Peter Tassiopoulos
|
Peter Tassiopoulos
|
Chief Executive Officer
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Sphere 3D Corp.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report;
|
4.
|
The company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:
|
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
(c)
|
Evaluated the effectiveness of the issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
(d)
|
Disclosed in this report any change in the issuer’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the issuer’s internal control over financial reporting; and
|
5.
|
The company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer’s auditors and the audit committee of the issuer’s board of directors (or persons performing the equivalent functions):
|
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer’s ability to record, process, summarize and report financial information; and
|
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer’s internal control over financial reporting.
|
/s/ Kurt L. Kalbfleisch
|
Kurt L. Kalbfleisch
|
Senior Vice-President and
|
Chief Financial Officer
|
•
|
|
The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
|
•
|
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
|
/s/ Peter Tassiopoulos
|
Peter Tassiopoulos
|
Chief Executive Officer
|
•
|
|
The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
|
•
|
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ Kurt L. Kalbfleisch
|
Kurt L. Kalbfleisch
|
Senior Vice-President and
|
Chief Financial Officer
|